KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

West Pharmaceutical Services (WST) Receivables - Net (2016 - 2025)

West Pharmaceutical Services' Receivables - Net history spans 17 years, with the latest figure at $574.4 million for Q4 2025.

  • For Q4 2025, Receivables - Net rose 3.96% year-over-year to $574.4 million; the TTM value through Dec 2025 reached $574.4 million, up 3.96%, while the annual FY2025 figure was $574.4 million, 3.96% up from the prior year.
  • Receivables - Net for Q4 2025 was $574.4 million at West Pharmaceutical Services, down from $625.0 million in the prior quarter.
  • Across five years, Receivables - Net topped out at $625.0 million in Q3 2025 and bottomed at $465.7 million in Q1 2021.
  • The 5-year median for Receivables - Net is $516.2 million (2023), against an average of $520.8 million.
  • The largest annual shift saw Receivables - Net skyrocketed 41.07% in 2021 before it decreased 10.29% in 2024.
  • A 5-year view of Receivables - Net shows it stood at $489.0 million in 2021, then increased by 3.76% to $507.4 million in 2022, then increased by 0.91% to $512.0 million in 2023, then increased by 7.91% to $552.5 million in 2024, then grew by 3.96% to $574.4 million in 2025.
  • Per Business Quant, the three most recent readings for WST's Receivables - Net are $574.4 million (Q4 2025), $625.0 million (Q3 2025), and $582.4 million (Q2 2025).